News
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.
Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback